These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 28526446

  • 1. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
    Ebrahimi SS, Oryan S, Izadpanah E, Hassanzadeh K.
    Toxicol Lett; 2017 Jul 05; 276():108-114. PubMed ID: 28526446
    [Abstract] [Full Text] [Related]

  • 2. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
    Rahimmi A, Khosrobakhsh F, Izadpanah E, Moloudi MR, Hassanzadeh K.
    Brain Res Bull; 2015 Apr 05; 113():34-40. PubMed ID: 25732239
    [Abstract] [Full Text] [Related]

  • 3. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul 05; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 4. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
    Zaitone SA, Ahmed E, Elsherbiny NM, Mehanna ET, El-Kherbetawy MK, ElSayed MH, Alshareef DM, Moustafa YM.
    Pharmacol Rep; 2019 Feb 05; 71(1):32-41. PubMed ID: 30368226
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study.
    Zhang ZN, Zhang JS, Xiang J, Yu ZH, Zhang W, Cai M, Li XT, Wu T, Li WW, Cai DF.
    Brain Res; 2017 Jan 15; 1655():104-113. PubMed ID: 27876560
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
    Teerapattarakan N, Benya-Aphikul H, Tansawat R, Wanakhachornkrai O, Tantisira MH, Rodsiri R.
    Phytomedicine; 2018 May 15; 44():65-73. PubMed ID: 29895494
    [Abstract] [Full Text] [Related]

  • 9. Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
    Kandil EA, Abdelkader NF, El-Sayeh BM, Saleh S.
    Neuroscience; 2016 Sep 22; 332():26-37. PubMed ID: 27365173
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 22; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Grammatopoulos TN, Ahmadi F, Jones SM, Fariss MW, Weyhenmeyer JA, Zawada WM.
    Brain Res; 2005 May 31; 1045(1-2):64-71. PubMed ID: 15910763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
    Kikuchi Y, Yasuhara T, Agari T, Kondo A, Kuramoto S, Kameda M, Kadota T, Baba T, Tajiri N, Wang F, Tayra JT, Liang H, Miyoshi Y, Borlongan CV, Date I.
    J Cell Physiol; 2011 May 31; 226(5):1390-8. PubMed ID: 20945350
    [Abstract] [Full Text] [Related]

  • 16. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
    Saravanan KS, Sindhu KM, Mohanakumar KP.
    Brain Res; 2005 Jul 12; 1049(2):147-55. PubMed ID: 15936733
    [Abstract] [Full Text] [Related]

  • 17. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
    Alabi AO, Ajayi AM, Ben-Azu B, Omorobge O, Umukoro S.
    Metab Brain Dis; 2019 Dec 12; 34(6):1723-1736. PubMed ID: 31463866
    [Abstract] [Full Text] [Related]

  • 18. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
    Garabadu D, Agrawal N.
    Neuromolecular Med; 2020 Jun 12; 22(2):314-330. PubMed ID: 31916219
    [Abstract] [Full Text] [Related]

  • 19. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM, Sherer TB, Greenamyre JT.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):109-18. PubMed ID: 15790535
    [Abstract] [Full Text] [Related]

  • 20. Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
    Güzelad Ö, Özkan A, Parlak H, Sinen O, Afşar E, Öğüt E, Yıldırım FB, Bülbül M, Ağar A, Aslan M.
    Metab Brain Dis; 2021 Jun 24; 36(5):1003-1014. PubMed ID: 33666819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.